Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Relay Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 125 | 132 | +7 |
| Shares | 89.1M | 91.8M | +2.63M (+3.0%) |
| Value | $3.26B | $2.89B | −$366.8M (−11.2%) |
New holders (21)
Institutions that held Relay Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 191,891 | $6.05M | 0.02% |
| Renaissance Technologies LLC | 152,588 | $4.81M | 0.01% |
| Fred Alger Management, LLC | 93,938 | $2.96M | 0.01% |
| PDT Partners, LLC | 87,652 | $2.76M | 0.20% |
| Blackstone Group Inc. | 35,618 | $1.12M | 0.00% |
| Jane Street Group, LLC | 19,364 | $611.0K | 0.00% |
| Millennium Management LLC | 17,758 | $560.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 11,340 | $358.0K | 0.04% |
| Point72 Hong Kong Ltd | 11,267 | $355.0K | 0.03% |
| Virtu Financial LLC | 7,512 | $237.0K | 0.02% |
| Aigen Investment Management, LP | 7,328 | $231.0K | 0.04% |
| DuPont Capital Management Corp | 7,282 | $230.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 7,300 | $230.0K | 0.00% |
| Marshall Wace North America L.P. | 6,600 | $208.0K | 0.00% |
| Quantbot Technologies LP | 4,800 | $151.0K | 0.01% |
| STRS Ohio | 3,100 | $97.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,799 | $88.0K | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,000 | $32.0K | 0.00% |
| Russell Investments Group, Ltd. | 871 | $27.0K | 0.00% |
| Signaturefd, LLC | 495 | $16.0K | 0.00% |
| Bell Investment Advisors, Inc | 31 | $1.00K | 0.00% |
Sold out (14)
Institutions that held Relay Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Foresite Capital Management IV, LLC | 556,380 | $20.4M |
| Foresite Capital Management V, LLC | 400,000 | $14.6M |
| OrbiMed Advisors LLC | 350,000 | $12.8M |
| California Public Employees Retirement System | 125,651 | $4.60M |
| Darwin Global Management, Ltd. | 119,775 | $4.38M |
| TCW Group Inc | 80,943 | $2.96M |
| Hershey Trust Co | 59,360 | $2.17M |
| Nomura Asset Management Co Ltd | 14,000 | $512.3K |
| Commonwealth Equity Services, LLC | 8,448 | $309.0K |
| Quantitative Systematic Strategies LLC | 8,246 | $302.0K |
| Dimensional Fund Advisors LP | 6,236 | $228.0K |
| FORA Capital, LLC | 1,010 | $37.0K |
| Savior LLC | 40 | $1.00K |
| Captrust Financial Advisors | 7 | $0 |